Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YB-01 in advanced solid tumors
NCT05986981Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2023
- Modality
- Whole Cell Cancer Vaccines, Peptides, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MUC1 vaccine in solid tumor, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
MUC1 vaccine
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05986981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05986981.